Name: BSX Debt Components
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

BOSTON SCIENTIFIC CORPORATION (BSX) Debt Components

2026-06-30: Debt, CurrentUSD $1.71B; Long-term Debt and Lease ObligationUSD $10.91B; Debt Instrument, Fair Value DisclosureUSD $12.27B; Long-term Debt, Maturities, Repayments of Principal in Rolling Year TwoUSD (m).
2026-03-31: Debt, CurrentUSD $41.00M; Long-term Debt and Lease ObligationUSD $10.99B; Debt Instrument, Fair Value DisclosureUSD $10.59B; Long-term Debt, Maturities, Repayments of Principal in Rolling Year TwoUSD (m).
2025-12-31: Debt, CurrentUSD $299.00M; Long-term Debt and Lease ObligationUSD $11.14B; Debt Instrument, Fair Value DisclosureUSD $11.15B; Long-term Debt, Maturities, Repayments of Principal in Rolling Year TwoUSD (m).
2025-12-31: Debt, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m); Debt Instrument, Fair Value DisclosureUSD (m); Long-term Debt, Maturities, Repayments of Principal in Rolling Year TwoUSD $1.06B.

BOSTON SCIENTIFIC CORPORATION Debt Components

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period end	Debt, Current USD	Long-term Debt and Lease Obligation USD	Debt Instrument, Fair Value Disclosure USD	Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD	Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD	Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD	Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD	Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five USD	Senior Notes, Current USD	Long-term Debt, Current Maturities USD	Senior Notes USD	Long-term Debt USD	Long-Term Debt, Maturity, Year One USD	Long-Term Debt, Maturity, Year Two USD	Long-Term Debt, Maturity, Year Three USD	Long-Term Debt, Maturity, Year Four USD	Long-Term Debt, Maturity, Year Five USD	Long-Term Debt, Maturity, after Year Five USD	Line of Credit Facility, Fair Value of Amount Outstanding USD	Line of Credit Facility, Maximum Borrowing Capacity USD	Line of Credit Facility, Remaining Borrowing Capacity USD	Long-term Debt, Gross USD	Debt Instrument, Redemption Price, Percentage pure	Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD	Debt Instrument, Unamortized Discount USD	Debt Instrument, Decrease, Repayments (Deprecated 2013-01-31) USD	Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD
2026-06-30	$1.71B	$10.91B	$12.27B	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2026-03-31	$41.00M	$10.99B	$10.59B	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BECTON DICKINSON & CO (BDX)	United States	$48.834B	43.79
3M CO (MMM)	United States	$86.404B	27.87
DEXCOM INC (DXCM)	United States	$33.004B	25.42
WEST PHARMACEUTICAL SERVICES INC (WST)	United States	$26.288B	43.14
STRYKER CORP (SYK)	United States	$103.511B	32.39
Solventum Corp (SOLV)	United States	$15.085B	9.16
Penumbra Inc (PEN)	United States	$12.596B	77.33
BAXTER INTERNATIONAL INC (BAX)	United States	$12.139B	-10.35
GLOBUS MEDICAL INC (GMED)	United States	$9.977B	20.03
INSULET CORP (PODD)	United States	$9.420B	28.12